Ind-Swift
INDSWFTLTD · Pharma > Pharmaceuticals & Drugs · Chairman: S R Mehta · MD: Gopal Munjal · Listing date: Oct. 19, 2004 · Employees: 1338 · Chandigarh · http://www.indswiftltd.com

Stock Price vs Company Growth
1d
4.7%
1w
4.0%
1m
7.8%
3m
3.4%
6m
6.5%
1y
33.6%
5y
32.0%
10y
8.5%
all
2.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 22 4.7%
18.7
28.1
Company Overview

Sales
468 Cr
Growth: 5.1%
Profit after Tax
40.1 Cr
Growth: 181.8%
Micro Cap
119 Cr
P/E: 3.0x
Industry P/E: 41.4x
Fundamentals

Sales (Cr) ₹ 468
Growth 5.1%
EBITDA 7.1%
P/S 0.3x
Dividend 0.0%
P/E 3.0x
Book Value ₹ -122
PEG Ratio 0.6x
ROE -5.7%
P/B N/A
Shareholding Pattern

Institutions
United India Insurance Company Limited
1.76 %
Deepa Ram Kheria
1.6 %
Justin Pharmaceuticals Private Limited
1.59 %
Altruistic Trading Private Limited
1.54 %
Gravity Systems Private Limited
1.38 %
Promoters
Essix Biosciences Limited
31.45 %
S.R. Mehta
3.76 %
Gopal Munjal
3.61 %
V.R. Mehta
3.55 %
Sunita Jain
3.35 %
Others
Increase    Decrease    No change
Company Profile Detailed

Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company.
Investors (78)